Company Performance: Profitability, revenue growth, and market share directly impact investor confidence.

Industry Trends: The overall health and outlook of the pharmaceutical sector influence stock valuation.

Regulatory Changes: New drug approvals, policy shifts, and healthcare reforms can significantly alter market dynamics.

Economic Conditions: Inflation, interest rates, and GDP growth affect investment decisions and market sentiment.

Investor Sentiment: Positive or negative news, analyst ratings, and social media buzz drive buying and selling pressures.

Global Events: International events, trade wars, and geopolitical risks can impact the global economy and investor confidence.

Competitor Actions: Major moves by competing pharmaceutical companies influence market positioning and profitability.

Technological Advancements: Breakthroughs in drug development and manufacturing can create new opportunities or threats.

Market Liquidity: The ease with which shares can be bought or sold impacts price volatility.

Company Announcements: Mergers, acquisitions, partnerships, and major product launches influence stock perception.